3 | SEC Filings Hub

Filing metadata

Accession number: 0001104659-22-009928
Form type: Form 3
Filer: Adaptimmune Therapeutics PLC
CIK: CIK 1621227
Filed: Jan 31, 2022
Reporting period: Jan 31, 2022
Description: Initial ownership

Documents

0001104659-22-009928-index.htm

Complete submission

0001104659-22-009928.txt

directory listing

Filed by

Adaptimmune Therapeutics PLC